Melatonin-induced estrogen receptor α-mediated calbindin-D9k expression plays a role in H2O2-mediated cell death in rat pituitary GH3 cells

Journal of Pineal Research

Volumn 47, Issue 4, 2009, Pages 301-307

  Yoo, Yeong Min ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Bad; Calbindin D9k; ERK; Estrogen receptor; Melatonin

Indexed keywords

CALBINDIN; ESTROGEN RECEPTOR ALPHA; HYDROGEN PEROXIDE; MELATONIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL STRAIN GH3; CELL SURVIVAL; CONTROLLED STUDY; DRUG BINDING; GENE OVEREXPRESSION; HYPOPHYSIS; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL LINE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; IMMUNOPRECIPITATION; MELATONIN; OXIDANTS; RATS;

EID: 70350053114     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00714.x     Document Type: Article

References (45)

1. de Jager T, Pelzer T, Müller-Botz S et al. Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. J Biol Chem 2001 276 : 27873 27880.
2. Choi KC, Jeung EB. The biomarker and endocrine disruptors in mammals. J Reprod Dev 2003 49 : 337 345.
3. Cos S, González A, Martínez-Campa C et al. Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Targets 2008 8 : 691 702.
4. McGee TD, Edwards J, Roitberg AE. Preliminary molecular dynamic simulations of the estrogen receptor alpha ligand binding domain from antagonist to apo. Int J Environ Res Public Health 2008 5 : 111 114.
5. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008 6 : e003.
6. Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia 1993 49 : 654 664.
7. Chemineau P, Guillaume D, Migaud M et al. Seasonality of reproduction in mammals: intimate regulatory mechanisms and practical implications. Reprod Domest Anim 2008 43 (Suppl. 2 40 47.
8. Pizarro JG, Yeste-Velasco M, Esparza JL et al. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res 2008 45 : 8 16.
9. Sainz RM, Reiter RJ, Tan DX et al. Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J Pineal Res 2008 45 : 258 270.
10. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
11. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
12. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
13. Gitto E, Pellegrino S, Gitto P et al. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009 46 : 128 139.
14. Reiter RJ, Tan DX, Korkmaz A et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncog 2007 13 : 303 328.
15. Harrod CG, Bendok BR, Hunt Batjer H. Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging. Med Hypotheses 2005 64 : 725 735.
16. Choi KC, Leung PC, Jeung EB. Biology and physiology of calbindin-D9k in female reproductive tissues: involvement of steroids and endocrine disruptors. Reprod Biol Endocrinol 2005 3 : 66.
17. Lee GS, Choi KC, Park SM et al. Expression of human calbindin-D(9k) correlated with age, vitamin D receptor and blood calcium level in the gastrointestinal tissues. Clin Biochem 2003 36 : 255 261.
18. Nguyen TH, Lee GS, Ji YK et al. A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle. Brain Res Mol Brain Res 2005 141 : 166 173.
19. Tinnanooru P, Dang VH, Nguyen TH et al. Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERalpha-pathway. Mol Cell Endocrinol 2008 285 : 26 33.
20. Choi KC, Jeung EB. Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: a review of current research. J Cell Mol Med 2008 12 : 409 420.
21. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992 15 : 303 308.
22. Guo Q, Christakos S, Robinson N, Mattson MP. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA 1998 95 : 3227 3232.
23. D'Orlando C, Fellay B, Schwaller B et al. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res 2001 909 : 145 158.
24. D'Orlando C, Celio MR, Schwaller B. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 2002 945 : 181 190.
25. Geula C, Nagykery N, Wu CK, Bu J. Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to plaques and tangles. J Neuropathol Exp Neurol 2003 62 : 605 616. (Pubitemid 36682633)
26. Yenari MA, Minami M, Sun GH et al. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 2001 32 : 1028 1035.
27. Yoo YM, Yim SV, Kim SS et al. Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells. J Pineal Res 2002 33 : 146 150.
28. Choi SI, Joo SS, Yoo YM. Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3beta and p-Bad in SK-N-MC cells. J Pineal Res 2008 44 : 95 100.
29. Tengattini S, Reiter RJ, Tan DX et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008 44 : 16 25.
30. Rezzani R, Rodella LF, Bonomini F et al. Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 2006 41 : 288 295.
31. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001 81 : 807 869.
32. Pearson G, Robinson F, Beers Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001 22 : 153 183.
33. Blalock WL, Pearce M, Steelman LS et al. A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells. Oncogene 2000 19 : 526 536.
34. Hoyle PE, Moye PW, Steelman LS et al. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 2000 14 : 642 656.
35. Kiefer T, Ram PT, Yuan L, Hill SM. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 2002 71 : 37 45.
36. Kiefer TL, Lai L, Yuan L et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005 38 : 231 239.
37. Rato AG, Pedrero JG, Martinez MA et al. Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J 1999 13 : 857 868.
38. Sánchez-Barceló EJ, Cos S, Mediavilla D et al. Melatonin-estrogen interactions in breast cancer. J Pineal Res 2005 38 : 217 222.
39. Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 2000 28 : 111 118.
40. Kuiper GGJM, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997 138 : 863 870. (Pubitemid 27089735)
41. Yoon K, Pellaroni L, Ramamoorthy K et al. Ligand structure-dependent differences in activation of estrogen receptor in human HepG2 liver and U2 oestrogenic cancer cell lines. Mol Cell Endocrinol 2000 162 : 211 220.
42. Van NT, Raber M, Barrows GH, Barlogie B. Estrogen receptor analysis by flow cytometry. Science 1984 224 : 876 879.
43. Lonsdorfer M, Clements NC Jr., Wittliff JL. Use of high-performance liquid chromatography in the evaluation of the synthesis and binding of fluorescein-linked steroids to estrogen receptors. J Chromatogr 1983 266 : 129 139.
44. Anstead GM, Altenbach RJ, Wilson SR, Katzenellenbogen JA. 2,3-Diarylindens and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenes. J Med Chem 1988 31 : 1316 1326.
45. Carlson KE, Coppey M, Magdelenat H, Katzenellenbogen JA. Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations. J Steroid Biochem 1989 32 : 345 355.